ENZON PHARM - Dusseldorf Stock Exchang
ENZON PHARM - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
ENZON PHARM - Dusseldorf Stock Exchang (EZ1) - Total Liabilities
Latest total liabilities as of September 2024: €44.51 Million EUR
Based on the latest financial reports, ENZON PHARM - Dusseldorf Stock Exchang (EZ1) has total liabilities worth €44.51 Million EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ENZON PHARM - Dusseldorf Stock Exchang - Total Liabilities Trend (2016–2023)
This chart illustrates how ENZON PHARM - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ENZON PHARM - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of ENZON PHARM - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CHU KONG PETRO GAS
BE:YCK
|
Germany | €5.35 Billion |
|
CHINA WINDPOWER - Dusseldorf Stock Exchang
DU:HK51
|
Germany | €22.80 Billion |
|
BEIJING JINGKELNG-H
MU:G2M
|
Germany | €5.30 Billion |
|
Indonesia Prima Property Tbk
JK:OMRE
|
Indonesia | Rp658.73 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down ENZON PHARM - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 107.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 16.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.94 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ENZON PHARM - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ENZON PHARM - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual total liabilities of ENZON PHARM - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €44.20 Million | +0.03% |
| 2022-12-31 | €44.18 Million | +3.02% |
| 2021-12-31 | €42.89 Million | +4.93% |
| 2020-12-31 | €40.87 Million | +9562.41% |
| 2019-12-31 | €423.00K | -18.18% |
| 2018-12-31 | €517.00K | +40.49% |
| 2017-12-31 | €368.00K | -60.85% |
| 2016-12-31 | €940.00K | -- |